 | ||||||
| "anti diabetes" | ||||||
| NEWS | ||||||
| AstraZeneca Diabetes Drug Combination Shows Promise in Study Astra's clinical trial was the first to combine the two types of anti-diabetes medicines. Its competitors Sanofi, Novo and Eli Lilly are betting on their own ... AstraZeneca (AZN) Announces Significant Data from Bydureon Combo Phase 3 in T2D Patients - StreetInsider.com
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.